Colonisation of Group B
Infant
Child
Pregnancy
Female
Humans
Adult
Pregnant Women
Retrospective Studies
Pregnancy Outcome
/ epidemiology
Fetal Distress
Streptococcal Infections
/ epidemiology
Risk Factors
Streptococcus agalactiae
Pregnancy Complications, Infectious
/ epidemiology
Premature Birth
/ epidemiology
Abortion, Spontaneous
Infectious diseases & infestations
MICROBIOLOGY
Public health
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
27 Nov 2023
27 Nov 2023
Historique:
medline:
29
11
2023
pubmed:
28
11
2023
entrez:
27
11
2023
Statut:
epublish
Résumé
This study was to investigate the colonisation rate of Group B A retrospective cohort study. Data of 47 380 pregnant women from 2016 to 2022 were collected from the Maternal and Child Health Hospital of Huadu District, Guangzhou City, China. A total of 15 040 pregnant women were eligible for this study, of which 32 340 were excluded due to non-native pregnant women, in vitro fertilization infants, malformed fetuses, habitual abortion, abortions due to poor reproductive or obstetrical history, artificial insemination, umbilical cord torsion, and other diseases during pregnancy. The incidence rates of GBS colonisation and premature delivery, fetal distress, premature rupture of membranes (PROM), low birth weight (LBW), abortion and stillbirth. Of the 15 040 pregnant women included in this study, 1445 developed GBS colonisation, with a prevalence of 9.61% (95% CI, 9.15 to 10.09). Advanced maternal age (≥35 years) predisposed women to GBS colonisation, and the occurrence of GBS colonisation varied among different ethnic groups. Our data revealed that fetal distress, PROM and LBW were more common in pregnant women colonised with GBS than in pregnant women not colonised with GBS. The incidence for premature delivery, fetal distress, PROM and LBW in infants of pregnant women colonised with GBS was 41.0% (OR=1.410, 95% CI, 1.134 to 1.753), 282.5% (OR=3.825, 95% CI, 3.185 to 4.593), 14.9% (OR=1.149, 95% CI, 1.005 to 1.313), and 29.7% (OR=1.297, 95% CI, 1.010 to 1.664), respectively. GBS colonisation was relatively low in pregnant women in Guangzhou. Women of advanced maternal age were more prone to GBS colonisation, and pregnant women colonised with GBS were more predisposed to fetal distress, PROM and LBW.
Identifiants
pubmed: 38011982
pii: bmjopen-2023-078759
doi: 10.1136/bmjopen-2023-078759
pmc: PMC10685966
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e078759Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Adv Nurs. 2022 Oct;78(10):3247-3260
pubmed: 35429021
EMBO Mol Med. 2015 Mar 06;7(4):488-505
pubmed: 25750210
Pathogens. 2022 Sep 28;11(10):
pubmed: 36297171
Clin Infect Dis. 2000 Feb;30(2):276-81
pubmed: 10671328
BMC Infect Dis. 2018 Jan 8;18(1):14
pubmed: 29310577
Eur J Obstet Gynecol Reprod Biol. 2021 Dec;267:274-279
pubmed: 34839249
Int J Clin Pract. 2021 Oct;75(10):e14683
pubmed: 34331733
Arch Dis Child. 2019 Feb;104(2):172-178
pubmed: 30018069
J Immunol. 2014 Feb 15;192(4):1718-31
pubmed: 24453257
Am J Obstet Gynecol. 2001 Feb;184(3):427-33
pubmed: 11228498
Lancet. 2012 Feb 11;379(9815):547-56
pubmed: 22226047
BJOG. 2014 Sep;121(10):1263-72; discussion 1273
pubmed: 24862166
BMC Pregnancy Childbirth. 2021 Feb 16;21(1):141
pubmed: 33593322
Am J Reprod Immunol. 2015 Mar;73(3):263-72
pubmed: 25263616
Lancet Glob Health. 2022 Jun;10(6):e807-e819
pubmed: 35490693
PLoS One. 2022 Apr 1;17(4):e0264309
pubmed: 35363775
Acta Obstet Gynecol Scand. 2010;89(2):250-5
pubmed: 19916889
Clin Infect Dis. 2017 Nov 06;65(suppl_2):S125-S132
pubmed: 29117322
MMWR Recomm Rep. 2002 Aug 16;51(RR-11):1-22
pubmed: 12211284
Clin Infect Dis. 2017 Nov 06;65(suppl_2):S112-S124
pubmed: 29117328
BMC Infect Dis. 2018 Jul 3;18(1):291
pubmed: 29970020
Dan Med J. 2014 Sep;61(9):A4908
pubmed: 25186546
Sci Rep. 2017 Nov 28;7(1):16454
pubmed: 29184151
J Exp Med. 2013 Jun 3;210(6):1265-81
pubmed: 23712433
BJOG. 2019 Oct;126(11):1347-1353
pubmed: 30734508
J Microbiol Immunol Infect. 2021 Dec;54(6):1094-1100
pubmed: 32826191
BJOG. 2022 Jan;129(2):233-240
pubmed: 34324252
Clin Exp Immunol. 2020 Jul;201(1):58-75
pubmed: 32279324
Turk Patoloji Derg. 2019;35(1):28-35
pubmed: 30614512
Cureus. 2021 Feb 17;13(2):e13395
pubmed: 33758696
Am J Obstet Gynecol. 2007 Oct;197(4):390.e1-4
pubmed: 17904972
Infect Dis Obstet Gynecol. 2000;8(3-4):138-42
pubmed: 10968595
Biosci Rep. 2019 Dec 20;39(12):
pubmed: 31820803
Front Cell Infect Microbiol. 2021 Sep 03;11:720789
pubmed: 34540718
Clin Infect Dis. 2017 Nov 06;65(suppl_2):S100-S111
pubmed: 29117327
BMC Infect Dis. 2021 May 27;21(1):492
pubmed: 34044786
Clin Infect Dis. 2017 Nov 06;65(suppl_2):S133-S142
pubmed: 29117329
MMWR Recomm Rep. 2010 Nov 19;59(RR-10):1-36
pubmed: 21088663
BJOG. 2014 Mar;121 Suppl 1:40-8
pubmed: 24641534
BMC Public Health. 2009 Dec 01;9:437
pubmed: 19948075
Clin Vaccine Immunol. 2013 Sep;20(9):1381-7
pubmed: 23825191